MTM + CHW Support for Type 2 Diabetes
(ENRxICH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best ways to help adults with type 2 diabetes manage their condition more effectively. The study aims to determine which type of support—either from a pharmacist for Medication Therapy Management (MTM), from a Community Health Worker (CHW) for addressing life challenges, or both—can enhance diabetes self-management. Participants will be randomly assigned to one of four groups: usual care, pharmacist support, CHW support, or both supports combined. The trial seeks adults with type 2 diabetes who are taking diabetes medication and have difficulty managing their blood sugar levels. As an unphased trial, it offers participants the chance to contribute to innovative diabetes care strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you will continue your current diabetes medications, as the study aims to improve medication management.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Medication Therapy Management (MTM) is generally safe for people with diabetes. One study found that patients using MTM services had better control of their blood sugar levels. Another review indicated that MTM can help lower healthcare costs and improve medication use. However, it also revealed that many patients had medication issues needing attention.
Studies suggest that Community Health Worker (CHW) support is safe and well-received. CHWs have effectively helped people manage type 2 diabetes by improving blood sugar levels and lifestyle habits. This support focuses on education and guidance, ensuring safety.
Combining MTM with CHW support also appears safe. Studies on this combination show improvements in managing medications and making lifestyle changes. While these findings are positive, each person’s experience can differ. Participants should discuss any concerns with their healthcare provider.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative support methods for managing Type 2 diabetes. Unlike standard treatments that focus primarily on medication management and lifestyle changes, this trial investigates the impact of Community Health Worker (CHW) support and Medication Therapy Management (MTM) on patient outcomes. CHWs provide personalized, community-based support, helping patients navigate healthcare systems and adhere to treatment plans. MTM offers a systematic approach to optimizing medication use and improving therapeutic outcomes. The combination of CHW and MTM might lead to more effective, personalized care by addressing both medical and social aspects of diabetes management.
What evidence suggests that this trial's treatments could be effective for type 2 diabetes?
Research has shown that Medication Therapy Management (MTM), a treatment in this trial, can significantly assist people with type 2 diabetes. Studies have found that MTM helps patients adhere to their medication plans, leading to better health and fewer hospital visits. Support from Community Health Workers (CHWs), another treatment option in this trial, also shows promise. It helps individuals manage their blood sugar and control diabetes, especially in areas with high diabetes rates. This trial will test the combination of MTM with CHW support, which may offer additional benefits, such as lowering blood sugar and enhancing overall well-being. This combination could be particularly effective for managing diabetes.678910
Who Is on the Research Team?
Michelle Chui, PharmD, PhD
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for Black and Hispanic adults aged 18-90 with type 2 diabetes, who speak English or Spanish. They must live in the study area, have a phone, take diabetes medication from the study pharmacy, and have an HbA1c of at least 8%. They can't join if they've had similar medicine management support recently or are in another program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of four interventions: usual care, Medication Therapy Management (MTM), Community Health Worker (CHW) support, or both MTM and CHW support for 6 months
Follow-up
Participants are monitored for changes in medication adherence and HbA1c levels
Long-term follow-up
Participants' medication adherence and HbA1c levels are assessed at 12 months
What Are the Treatments Tested in This Trial?
Interventions
- CHW
- MTM
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator